782483-71-0Relevant academic research and scientific papers
Substituted carboxylic acids
-
Page/Page column 19, (2010/11/08)
The present invention relates to compounds and pharmaceutically acceptable salts of formula I: which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosine
Substituted phenylalkanoic acids
-
Page/Page column 23, (2010/11/08)
The present invention relates to compounds and pharmaceutically acceptable salts of formula I: which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosine
SUBSTITUTED CARBOXYLIC ACIDS
-
Page 60-61, (2008/06/13)
The present invention relates to compounds and pharmaceutically acceptable salts of formula (I) : which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosi
SUBSTITUTED PHENYLALKANOIC ACIDS
-
Page 84, (2010/02/09)
The present invention relates to compounds and pharmaceutically acceptable salts of formula (I), which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosin
Substituted phenylalkanoic acids for the treatment of diabetes
-
Page 32, (2010/02/09)
The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosine phosphatase (PTP-1B) that are useful in the treatment of diabetes and other PTP-1B mediated diseases, such as cancer, neurodegenerative diseases and the like. The compounds of the invention are also useful in pharmaceutical compositions and methods of treating the aforementioned conditions.
